Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 272Head and Neck Neoplasms 241Carcinoma, Non-Small-Cell Lung 92Thyroid Neoplasms 85Melanoma 67Mouth Neoplasms 64Oropharyngeal Neoplasms 61Nasopharyngeal Carcinoma 60Breast Neoplasms 51Colorectal Neoplasms 49Ovarian Neoplasms 44Lung Neoplasms 44Neoplasm Metastasis 43Carcinoma, Squamous Cell 39Uterine Cervical Neoplasms 38Neoplasms 37Carcinoma, Renal Cell 33Stomach Neoplasms 31Laryngeal Neoplasms 31Triple Negative Breast Neoplasms 29Carcinoma 28Esophageal Neoplasms 27Endometrial Neoplasms 27Sarcoma 26Pancreatic Neoplasms 26Salivary Gland Neoplasms 24Prostatic Neoplasms 23Hypopharyngeal Neoplasms 22Urinary Bladder Neoplasms 21Thyroid Cancer, Papillary 21

Interventions

ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ototoxicity × Head & Neck × 90 days × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT07622407 2026-06-03

TIMELY REHAB

VA Office of Research and Development

Phase NA Not yet recruiting
74 enrolled
Head & Neck

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡